Review



human cc cell lines  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC human cc cell lines
    Human Cc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1109 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cc cell lines/product/ATCC
    Average 96 stars, based on 1109 article reviews
    human cc cell lines - by Bioz Stars, 2026-05
    96/100 stars

    Images



    Similar Products

    96
    ATCC human cc cell lines
    Human Cc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cc cell lines/product/ATCC
    Average 96 stars, based on 1 article reviews
    human cc cell lines - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    86
    Procell Inc human cc cell line ca ski
    Human Cc Cell Line Ca Ski, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cc cell line ca ski/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    human cc cell line ca ski - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Procell Inc human cc cell lines hela cl 0101
    Human Cc Cell Lines Hela Cl 0101, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cc cell lines hela cl 0101/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    human cc cell lines hela cl 0101 - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    86
    Procell Inc treatment human cc cell lines hela
    Treatment Human Cc Cell Lines Hela, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/treatment human cc cell lines hela/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    treatment human cc cell lines hela - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    99
    ATCC human cc cell line hela
    NRF2 signaling inhibition sensitizes CC cells to cisplatin treatment. ( A ) IC50 values of <t>HeLa,</t> <t>SiHa</t> and C33A cells treated with cisplatin for 48 h. The data are representative of 3 biological replicates. ( B ) IC50 values of HeLa, SiHa and C33A cells treated with cisplatin for 48 h. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure, with ML385 maintained throughout the entire treatment period. The data are representative of 3 biological replicates. ( C ) RT-qPCR showing the mRNA expression of NQO1 in CC cell lines. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure. The data are representative of 3 biological replicates. ( D ) Representative histograms and gMFI of DCFH-DA in SiHa and HeLa cells. The data are representative of 3 biological replicates. *p< 0.05, **p< 0.01, ***p< 0.001.
    Human Cc Cell Line Hela, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cc cell line hela/product/ATCC
    Average 99 stars, based on 1 article reviews
    human cc cell line hela - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    86
    Human Protein Atlas human cc cell lines
    NRF2 signaling inhibition sensitizes CC cells to cisplatin treatment. ( A ) IC50 values of <t>HeLa,</t> <t>SiHa</t> and C33A cells treated with cisplatin for 48 h. The data are representative of 3 biological replicates. ( B ) IC50 values of HeLa, SiHa and C33A cells treated with cisplatin for 48 h. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure, with ML385 maintained throughout the entire treatment period. The data are representative of 3 biological replicates. ( C ) RT-qPCR showing the mRNA expression of NQO1 in CC cell lines. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure. The data are representative of 3 biological replicates. ( D ) Representative histograms and gMFI of DCFH-DA in SiHa and HeLa cells. The data are representative of 3 biological replicates. *p< 0.05, **p< 0.01, ***p< 0.001.
    Human Cc Cell Lines, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cc cell lines/product/Human Protein Atlas
    Average 86 stars, based on 1 article reviews
    human cc cell lines - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    99
    ATCC cell lines human cc cell line hela
    NRF2 signaling inhibition sensitizes CC cells to cisplatin treatment. ( A ) IC50 values of <t>HeLa,</t> <t>SiHa</t> and C33A cells treated with cisplatin for 48 h. The data are representative of 3 biological replicates. ( B ) IC50 values of HeLa, SiHa and C33A cells treated with cisplatin for 48 h. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure, with ML385 maintained throughout the entire treatment period. The data are representative of 3 biological replicates. ( C ) RT-qPCR showing the mRNA expression of NQO1 in CC cell lines. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure. The data are representative of 3 biological replicates. ( D ) Representative histograms and gMFI of DCFH-DA in SiHa and HeLa cells. The data are representative of 3 biological replicates. *p< 0.05, **p< 0.01, ***p< 0.001.
    Cell Lines Human Cc Cell Line Hela, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell lines human cc cell line hela/product/ATCC
    Average 99 stars, based on 1 article reviews
    cell lines human cc cell line hela - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    96
    ATCC human cc cell lines me180
    NRF2 signaling inhibition sensitizes CC cells to cisplatin treatment. ( A ) IC50 values of <t>HeLa,</t> <t>SiHa</t> and C33A cells treated with cisplatin for 48 h. The data are representative of 3 biological replicates. ( B ) IC50 values of HeLa, SiHa and C33A cells treated with cisplatin for 48 h. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure, with ML385 maintained throughout the entire treatment period. The data are representative of 3 biological replicates. ( C ) RT-qPCR showing the mRNA expression of NQO1 in CC cell lines. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure. The data are representative of 3 biological replicates. ( D ) Representative histograms and gMFI of DCFH-DA in SiHa and HeLa cells. The data are representative of 3 biological replicates. *p< 0.05, **p< 0.01, ***p< 0.001.
    Human Cc Cell Lines Me180, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cc cell lines me180/product/ATCC
    Average 96 stars, based on 1 article reviews
    human cc cell lines me180 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    98
    ATCC human cc cell line siha
    NRF2 signaling inhibition sensitizes CC cells to cisplatin treatment. ( A ) IC50 values of <t>HeLa,</t> <t>SiHa</t> and C33A cells treated with cisplatin for 48 h. The data are representative of 3 biological replicates. ( B ) IC50 values of HeLa, SiHa and C33A cells treated with cisplatin for 48 h. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure, with ML385 maintained throughout the entire treatment period. The data are representative of 3 biological replicates. ( C ) RT-qPCR showing the mRNA expression of NQO1 in CC cell lines. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure. The data are representative of 3 biological replicates. ( D ) Representative histograms and gMFI of DCFH-DA in SiHa and HeLa cells. The data are representative of 3 biological replicates. *p< 0.05, **p< 0.01, ***p< 0.001.
    Human Cc Cell Line Siha, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cc cell line siha/product/ATCC
    Average 98 stars, based on 1 article reviews
    human cc cell line siha - by Bioz Stars, 2026-05
    98/100 stars
      Buy from Supplier

    Image Search Results


    NRF2 signaling inhibition sensitizes CC cells to cisplatin treatment. ( A ) IC50 values of HeLa, SiHa and C33A cells treated with cisplatin for 48 h. The data are representative of 3 biological replicates. ( B ) IC50 values of HeLa, SiHa and C33A cells treated with cisplatin for 48 h. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure, with ML385 maintained throughout the entire treatment period. The data are representative of 3 biological replicates. ( C ) RT-qPCR showing the mRNA expression of NQO1 in CC cell lines. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure. The data are representative of 3 biological replicates. ( D ) Representative histograms and gMFI of DCFH-DA in SiHa and HeLa cells. The data are representative of 3 biological replicates. *p< 0.05, **p< 0.01, ***p< 0.001.

    Journal: International Journal of Women's Health

    Article Title: Prediction of Cervical Cancer Progression Leveraging HPV16 Integration-Related Genes

    doi: 10.2147/IJWH.S543345

    Figure Lengend Snippet: NRF2 signaling inhibition sensitizes CC cells to cisplatin treatment. ( A ) IC50 values of HeLa, SiHa and C33A cells treated with cisplatin for 48 h. The data are representative of 3 biological replicates. ( B ) IC50 values of HeLa, SiHa and C33A cells treated with cisplatin for 48 h. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure, with ML385 maintained throughout the entire treatment period. The data are representative of 3 biological replicates. ( C ) RT-qPCR showing the mRNA expression of NQO1 in CC cell lines. Cells were pretreated with ML385 (1 µM) for 2 hours prior to cisplatin exposure. The data are representative of 3 biological replicates. ( D ) Representative histograms and gMFI of DCFH-DA in SiHa and HeLa cells. The data are representative of 3 biological replicates. *p< 0.05, **p< 0.01, ***p< 0.001.

    Article Snippet: Human CC cell line HeLa, SiHa and C33A were obtained from the American Type Culture Collection (ATCC).

    Techniques: Inhibition, Quantitative RT-PCR, Expressing